Benkowitz Michael's Form 4 filing
United Therapeutics Corp (UTHR) · filed Feb 4, 2025
- Accession no.
- 0001562180-25-000883
- Filed
- Feb 4, 2025
- Trade date
- Feb 3, 2025
- Filing delay
- 1 day
- Rule 10b5-1 plan
- Checked
This filing lists 20 non-derivative transactions and 2 derivative transactions. Open-market sales total $3.54M. It was filed 1 day after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Benkowitz MichaelCIK 0001673232 | Officer (PRESIDENT AND COO) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Feb 3, 2025 | Common Stock | MOption exerciseAcquired | +7,500 | $111.00 | +$832,500 | 7,500 | Indirect | |
| Feb 3, 2025 | Common Stock | SSaleDisposed | −600 | $347.32 | −$208,392 | 6,900 | Indirect | |
| Feb 3, 2025 | Common Stock | SSaleDisposed | −200 | $348.64 | −$69,728 | 6,700 | Indirect | |
| Feb 3, 2025 | Common Stock | SSaleDisposed | −418 | $350.37 | −$146,454.66 | 6,282 | Indirect | |
| Feb 3, 2025 | Common Stock | SSaleDisposed | −652 | $351.32 | −$229,060.64 | 5,630 | Indirect | |
| Feb 3, 2025 | Common Stock | SSaleDisposed | −1,121 | $352.37 | −$395,006.77 | 4,509 | Indirect | |
| Feb 3, 2025 | Common Stock | SSaleDisposed | −500 | $353.30 | −$176,650 | 4,009 | Indirect | |
| Feb 3, 2025 | Common Stock | SSaleDisposed | −1,005 | $354.80 | −$356,574 | 3,004 | Indirect | |
| Feb 3, 2025 | Common Stock | SSaleDisposed | −1,204 | $355.63 | −$428,178.52 | 1,800 | Indirect | |
| Feb 3, 2025 | Common Stock | SSaleDisposed | −1,600 | $356.81 | −$570,896 | 200 | Indirect | |
| Feb 3, 2025 | Common Stock | SSaleDisposed | −200 | $358.08 | −$71,616 | 0 | Indirect | |
| Feb 3, 2025 | Common Stock | MOption exerciseAcquired | +2,500 | $111.00 | +$277,500 | 2,500 | Indirect | |
| Feb 3, 2025 | Common Stock | SSaleDisposed | −200 | $347.05 | −$69,410 | 2,300 | Indirect | |
| Feb 3, 2025 | Common Stock | SSaleDisposed | −100 | $348.61 | −$34,861 | 2,200 | Indirect | |
| Feb 3, 2025 | Common Stock | SSaleDisposed | −100 | $350.05 | −$35,005 | 2,100 | Indirect | |
| Feb 3, 2025 | Common Stock | SSaleDisposed | −400 | $351.79 | −$140,716 | 1,700 | Indirect | |
| Feb 3, 2025 | Common Stock | SSaleDisposed | −400 | $353.13 | −$141,252 | 1,300 | Indirect | |
| Feb 3, 2025 | Common Stock | SSaleDisposed | −400 | $354.69 | −$141,876 | 900 | Indirect | |
| Feb 3, 2025 | Common Stock | SSaleDisposed | −400 | $355.58 | −$142,232 | 500 | Indirect | |
| Feb 3, 2025 | Common Stock | SSaleDisposed | −500 | $357.01 | −$178,505 | 0 | Indirect |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Feb 3, 2025 | Common Stock | MOption exerciseDisposed | −2,500 | $0.00 | $0 | 12,000 | Indirect | |
| Feb 3, 2025 | Common Stock | MOption exerciseDisposed | −7,500 | $0.00 | $0 | 29,679 | Indirect |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.